Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 1
Scientific Advances in Lung Cancer 2015.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
Times cited: 23
- Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014 Academic Article GET IT